Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinase during myocardial ischemia-reperfusion

Molecular and Cellular Biochemistry

Volumn 258, Issue 1-2, 2004, Pages 211-218

  Kumar, Dinender ^a,b   Menon, Vijayan ^a   Ford, William R ^a,c   Clanachan, Alexander S ^a   Jugdutt, Bodh I ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b University of Wisconsin Cardiovascular Research Center   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

AT2 receptor; ERK; Ischemia reperfusion; JNK 1 2; p38; PKCe cGMP

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CYCLIC GMP; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C EPSILON; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME IMMUNOASSAY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; HEART WORK; IMMUNOBLOTTING; ISOLATION PROCEDURE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; TISSUE LEVEL;

ANIMALS; CYCLIC GMP; IMIDAZOLES; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 1442306548     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000012857.06723.81     Document Type: Article

References (49)

1. Yoshiyama M, Kim S, Yamagishi H, Omura T, Tani T, Yanagi S, Toda I, Teragaki M, Akioka K, Takeuchi K, Takeda T: Cardioprotective effect of the angiotensin II type I receptor antagonist TCV-116 on ischemia-reperfusion injury. Am Heart J 128: 1-6, 1994
2. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993
3. Matsubara H: Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83: 1182-1191, 1998
4. Horiuchi M, Akishita M, Dzau VJ: Recent progress in angiotensin type 2 receptor research in the cardiovascular system. Hypertension 33: 613-621, 1999
5. Yamada T, Horiuchi M, Dzau VJ: Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93: 156-160, 1996
6. 2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation 94: 3087-3089, 1996
7. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M: Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95: 46-54, 1995
8. 2 angiotensin receptor gene expression in human heart failure. Circulation 95: 1201-1206, 1997
9. 2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. Am J Physiol 282: H1206-H1215, 2002
10. Xu Y, Clanachan AS, Jugdutt BI: Enhanced expression of angiotensin II type 2 receptor, inositol 1,4, 5-trisphosphate receptor, and protein kinase CE during cardioprotection induced by angiotensin II type 2 receptor blockade. Hypertension 36: 506-510, 2000
11. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31: 349-355, 1998
12. 2 receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 32: 1787-1796, 1998
13. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA: Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 99: 1926-1935, 1997
14. 3 receptor and PKCE proteins. J Renin Angiotensin Aldosterone Syst 1: 184-195, 2000
15. Moudgil R, Menon V, Xu Y, Musat-Marcu S, Kumar D, Jugdutt BI: Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in working rat hearts. J Hypertens 19: 1121-1129, 2001
16. 1R blockade. Can J Cardiol 18: 1107-1116, 2002
17. Gutkind JS: The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273: 1839-1842, 1998
18. Sugden PH, Clerk A: Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 9: 337-351, 1997
19. Hunyady L, Balla T, Catt KJ: The ligand binding site of the angiotensin AT1 receptor. Trends Pharmacol Sci 17: 135-140, 1996
20. 1 receptor blockade after reperfused myocardial infarction. J Renin-Angiotensin Aldosterone Syst 2: 134-140, 2001
21. Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995
22. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK: p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998
23. Hayashida W, Kihara Y, Yasaka A, Inagaki K, Iwanaga Y, Sasayama S: Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts. J Mol Cell Cardiol 33: 733-744, 2001
24. Schmitz U, Ishida T, Ishida M, Surapisitchat J, Hasham MI, Pelech S, Berk BC: Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: Role in activation of JNK. Circ Res 82: 1272-1278, 1998
25. Kudoh S, Komuro I, Mizuno T, Yamazaki T, Zou Y, Shiojima I, Takekoshi N, Yazaki Y: Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res 90: 139-146, 1997
26. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995
27. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556, 1993
28. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, Yazaki Y: Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 18 13-1821, 1997
29. Wang X, Martindale JL, Liu Y, Holbrook NJ: The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333: 291-300, 1998
30. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH: Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86: 692-699, 2000
31. Sugden PH, Clerk A: Stress-responsive mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 83: 345-352, 1998
32. Weinbrenner C, Liu GS, Cohen MV, Downey JM: Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29: 2383-2391, 1997
33. Zhao TC, Hines DS, Kukreja RC: Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels. Am J Physiol 280: H1278-H1285, 2001
34. Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M: Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res 88: 175-180, 2001
35. Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD: Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: Evidence for involvement of p38 MAPK. Circ Res 86: 144-151, 2000
36. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH: Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79: 162-173, 1996
37. Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, Chien KR: Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273: 2161-2168, 1998
38. Clerk A, Michael A, Sugden PH: Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy? J Cell Biol 142: 523-535, 1998
39. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, Banerjee S, Dawn B, Balafonova Z, Bolli R: Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: A signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 84: 587-604, 1999
40. Bartunek J, Weinberg EO, Tajima M, Rohrbach S, Lorell BH: Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts. Circulation 99: 22-25, 1999
41. 1 receptor blockade in reperfused myocardial infarction. In: N. Dhalla (ed). Signal Transduction and Cardiac Hypertrophy. Kluwer Academic Publishers, Boston, 2002, pp 221-236
42. Kyriakis JM, Avruch J: Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 271: 24313-24316, 1996
43. Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW, Plevin R: Stress-activated protein kinases: Activation, regulation and function. Cell Signal 9: 403-410, 1997
44. Sadoshima J, Qiu Z, Morgan JP, Izumo S: Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ Res 76: 1-15, 1995
45. Hayashida W, Horiuchi M, Dzau VJ: Intracellular third loop domain of angiotensin II type-2 receptor. Role in mediating signal transduction and cellular function. J Biol Chem 271: 21985-21992, 1996
46. Izumi Y, Kim S, Zhan Y, Namba M, Yasumoto H, Iwao H: Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats. Hypertension 36: 511-516, 2000
47. Thomas WG, Thekkumkara TJ, Baker KM: Cardiac effects of AII. AT1A receptor signaling, desensitization, and internalization. Adv Exp Med Biol 396: 59-69, 1996
48. Thorburn J, Frost JA, Thorburn A: Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol 126: 1565-1572, 1994
49. Post GR, Goldstein D, Thuerauf DJ, Glembotski CC, Brown JH: Dissoiation of p44 and p42 mitogen-activated protein kinase activation from rceceptor-induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 271: 8452-8457, 1996